BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30361825)

  • 1. Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer.
    Pecero ML; Salvador-Bofill J; Molina-Pinelo S
    Cell Oncol (Dordr); 2019 Feb; 42(1):1-12. PubMed ID: 30361825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
    Malih S; Saidijam M; Malih N
    Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance.
    Yousefi H; Maheronnaghsh M; Molaei F; Mashouri L; Reza Aref A; Momeny M; Alahari SK
    Oncogene; 2020 Jan; 39(5):953-974. PubMed ID: 31601996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal Long Non-Coding RNAs Expression Patterns Have the Potential Ability for Predicting Survival and Treatment Response in Breast Cancer.
    Pavanelli AC; Mangone FR; Barros LRC; Machado-Rugolo J; Capelozzi VL; Nagai MA
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34209776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.
    Wang J; Ye C; Xiong H; Shen Y; Lu Y; Zhou J; Wang L
    Oncotarget; 2017 Jan; 8(3):5508-5522. PubMed ID: 27732939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects.
    Wang MQ; Zhu WJ; Gao P
    Exp Mol Pathol; 2021 Jun; 120():104640. PubMed ID: 33878314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of long non-coding RNAs with a potential role in breast cancer.
    Heidari R; Akbariqomi M; Asgari Y; Ebrahimi D; Alinejad-Rokny H
    Mutat Res Rev Mutat Res; 2021; 787():108375. PubMed ID: 34083033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs in anti-cancer drug resistance.
    Chen QN; Wei CC; Wang ZX; Sun M
    Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
    Panoutsopoulou K; Avgeris M; Scorilas A
    Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing therapeutic resistance in breast cancer: from the lncRNAs perspective.
    Peng L; Jiang J; Tang B; Nice EC; Zhang YY; Xie N
    Theranostics; 2020; 10(23):10360-10377. PubMed ID: 32929354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNAs in regulation of human breast cancer.
    Wang G; Liu C; Deng S; Zhao Q; Li T; Qiao S; Shen L; Zhang Y; Lü J; Meng L; Liang C; Yu Z
    Brief Funct Genomics; 2016 May; 15(3):222-6. PubMed ID: 26582840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The network of non-coding RNAs and their molecular targets in breast cancer.
    Crudele F; Bianchi N; Reali E; Galasso M; Agnoletto C; Volinia S
    Mol Cancer; 2020 Mar; 19(1):61. PubMed ID: 32188472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer.
    Sun Z; Zhang C; Wang T; Shi P; Tian X; Guo Y
    J Cancer Res Ther; 2019; 15(4):933-940. PubMed ID: 31436255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Status of Long Non-Coding RNAs in Human Breast Cancer.
    Cerk S; Schwarzenbacher D; Adiprasito JB; Stotz M; Hutterer GC; Gerger A; Ling H; Calin GA; Pichler M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles of long non-coding RNAs in breast cancer biology and management.
    Amelio I; Bernassola F; Candi E
    Semin Cancer Biol; 2021 Jul; 72():36-45. PubMed ID: 32619506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
    Zhang X; Yang H
    Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNAs and neoplasia.
    Isin M; Dalay N
    Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
    Wang Q; Gao S; Li H; Lv M; Lu C
    J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.